Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 29, Issue 3, Pages 1536-1542
Publisher
Springer Nature
Online
2011-10-08
DOI
10.1007/s12032-011-0082-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
- (2010) H Wong et al. BRITISH JOURNAL OF CANCER
- Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
- (2010) Shelly S. Lo et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
- (2009) So-Youn Jung et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis
- (2009) Ping Tang et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy
- (2009) Filippo Montemurro et al. ENDOCRINE-RELATED CANCER
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
- (2009) Guido Sauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
- (2009) Kathy S Albain et al. LANCET
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
- (2009) Anees B. Chagpar et al. SURGERY
- Are the Pure In Situ Breast Ductal Carcinomas and Those Associated With Invasive Carcinoma the Same?
- (2009) Mario Casales Schorr et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93
- (2008) Olivia Pagani et al. BREAST CANCER RESEARCH AND TREATMENT
- Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study
- (2008) V. V. Iakovlev et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Chemotherapy Use for Hormone Receptor–Positive, Lymph Node–Negative Breast Cancer
- (2008) Michael J. Hassett et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now